Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 20/20 | 1.00 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.69 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.69 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.69 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7723285 | 1.00 | CCR5 (1.00) | CCR5CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7733748 | 0.95 | CCR5 (0.91) | CCR5CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7733745 | 0.95 | CCR5 (0.91) | CCR5CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7732663 | 0.94 | CCR5 (0.88) | CCR5CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7732665 | 0.94 | CCR5 (0.88) | CCR5CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7732621 | 0.89 | CCR5 (0.81) | CCR5CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7732617 | 0.89 | CCR5 (0.81) | CCR5CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7990985 | 0.86 | CCR5 (1.00) | CCR5CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7990987 | 0.86 | CCR5 (1.00) | CCR5CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL7931871 | 0.84 | CCR5 (0.78) | CCR5CACNA1FCACNA1DCACNA1SCACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6399619-B1 | PREVENTION AND TREATMENT OF AIDS AND VIRAL INFECTION BY HIV | MERCK & CO., INC. | 2002-06-04 | — | — | US | disclosed |